Swiss National Bank
LEGN icon

Swiss National Bank’s Legend Biotech LEGN Stock Holding History

Swiss National Bank’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99M Sell
138,294
-4,500
-3% -$121K ﹤0.01% 1568
2026
Q1 		$2.58M Sell
142,794
-18,500
-11% -$353K ﹤0.01% 1723
2025
Q4 		$3.51M Sell
161,294
-4,900
-3% -$140K ﹤0.01% 1567
2025
Q3 		$5.42M Buy
166,194
+20,500
+14% +$757K ﹤0.01% 1287
2025
Q2 		$5.17M Sell
145,694
-21,700
-13% -$703K ﹤0.01% 1275
2025
Q1 		$5.68M Buy
167,394
+400
+0.2% +$14.3K ﹤0.01% 1193
2024
Q4 		$5.43M Buy
166,994
+1,800
+1% +$74.6K ﹤0.01% 1285
2024
Q3 		$8.05M Buy
165,194
+5,200
+3% +$277K 0.01% 1048
2024
Q2 		$7.09M Hold
159,994
– – ﹤0.01% 1060
2024
Q1 		$8.97M Buy
159,994
+6,000
+4% +$362K 0.01% 973
2023
Q4 		$9.27M Buy
153,994
+14,400
+10% +$913K 0.01% 924
2023
Q3 		$9.38M Buy
139,594
+1,400
+1% +$97.2K 0.01% 915
2023
Q2 		$9.54M Sell
138,194
-9,700
-7% -$634K 0.01% 932
2023
Q1 		$7.13M Buy
147,894
+23,000
+18% +$1.12M ﹤0.01% 1057
2022
Q4 		$6.23M Hold
124,894
– – ﹤0.01% 1182
2022
Q3 		$5.1M Buy
124,894
+3,000
+2% +$141K ﹤0.01% 1262
2022
Q2 		$6.7M Hold
121,894
– – ﹤0.01% 1142
2022
Q1 		$4.43M Buy
121,894
+80,294
+193% +$3.17M ﹤0.01% 1518
2021
Q4 		$1.94M Buy
+41,600
New +$2.11M ﹤0.01% 2082

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Swiss National Bank's LEGN Position: Q2 2026 in Review

Swiss National Bank reduced its Legend Biotech (LEGN) stake by 3.2% in Q2 2026, selling an estimated $121K and leaving 138,294 shares worth $3.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Swiss National Bank first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.54M in Q2 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Swiss National Bank held 138,294 shares of Legend Biotech worth $3.99M as of Q2 2026.
  • Swiss National Bank sold 4,500 Legend Biotech shares in Q2 2026, an estimated $121K.
  • Legend Biotech made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1568 holding.
  • Swiss National Bank first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • Swiss National Bank's Legend Biotech position peaked at $9.54M in Q2 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.